Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Feldman, Becca S ^a   Cohen Stavi, Chandra J ^a   Leibowitz, Morton ^a,b   Hoshen, Moshe B ^a   Singer, Shepherd R ^c   Bitterman, Haim ^a,d   Lieberman, Nicky ^a   Balicer, Ran D ^a,e  

^a CLALIT HEALTH SERVICES   (Israel)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MINISTRY OF HEALTH   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; DIABETES MELLITUS; DISEASE DURATION; ELECTRONIC MEDICAL RECORD; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; PRESCRIPTION; RISK FACTOR; BLOOD; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84907908983     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108145     Document Type: Article

References (34)

1. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, et al. (2012) Diabetes in older adults. Diabetes Care 35:2650-64.
2. ADVANCE Collaboration Group, Patel A, MacMahon S, Chalmers J, Neal B, et al. (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572.
3. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321: 405-412.
4. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986.
5. Huang ES, Liu JY, Moffet HH, John PM, Karter AJ (2011) Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study. Diabetes Care 34: 1329-1336.
6. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, et al. (2006) Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 166: 1836-1841.
7. American Diabetes Association (2013) Standards of Medical Care in Diabetes - 2013. Diabetes Care (Suppl 1): S11-S66.
8. NCQA (2008) Comprehensive Diabetes Care. HEDIS 2009 Volume 2 Technical Update. Available: http://www.ncqa.org/portals/0/PolicyUpdates/HEDIS%20Technical%20Updates/09-CDC-Spec.pdf. Accessed 14 May 2013.
9. Tiv M, Viel JF, Mauny F, Eschwege E, Weill A, et al. (2012) Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PLoS One [Epub] 7: e32412.
10. Cramer JA (2004) A systematic review of adherence with medications for diabetes. Diabetes Care 27: 1218-1224.
11. Krapek K, King K, Warren SS, George KG, Caputo DA, et al. (2004) Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 38: 1357-62.
12. Donnan PT, MacDonald TM, Morris AD (2002) Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 19: 279-84.
13. Lopez J, Bailey RA, Rupnow MFT, Annunziata K (2014) Characterization of Type 2 Diabetes Mellitus Burden by Age and Ethnic Groups Based on a Nationwide Survey. Clin Ther 36(4): 494-506.
14. Long JA, Wong A, Medvedeva EL, Eisen SV, Gordon AJ, et al. (2014) Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter? Diabetes Care. 37: 2261-2267.
15. Arifulla M, John LJ, Sreedharan J, Muttappallymyalil J, Basha SA (2014) Patients' adherence to anti-diabetic medications in a hospital at Ajman, UAE. Malays J Med Sci 21: 44-49.
16. Egede LE, Gebregziabher M, Hunt KJ, Axon RN, Echols C, et al. (2011) Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes. Diabetes Care 34: 938-943.
17. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS (2008) Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care 14: 71-75.
18. Lawrence DB, Ragucci KR, Long LB, Parris BS, Helfer LA (2006) Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 12: 466-471.
19. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, et al. (2005) Patient adherence improves glycemic control. Diabetes Educ 31: 240-250.
20. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, et al. (2004) Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 27: 2800-2805.
21. Guillausseau PJ (2003) Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab 29: 79-81.
22. Schectman JM, Nadkarni MM, Voss JD (2002) The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 25: 1015-1021.
23. Asche C, LaFleur J, Conner C (2011) A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther 33: 74-109.
24. Gonzalez JS, Schneider HE (2011) Methodological issues in the assessment of diabetes treatment adherence. Curr Diab Rep 11: 472-479.
25. Juarez DT, Sentell T, Tokumaru S, Goo R, Davis JW, et al. (2012) Factors Associated With Poor Glycemic Control or Wide Glycemic Variability Among Diabetes Patients in Hawaii, 2006-2009. Prev Chronic Dis 9: 120065.
26. Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K (2010) Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications 24: 84-89.
27. Duckworth WC, Abraira C, Moritz TE, Davis SN, Emanuele N, et al. (2011) The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial. J Diabetes Complications 25: 355-361.
28. Moreira ED Jr, Neves RC, Nunes ZO, de Almeida MC, Mendes AB, et al. (2010) Glycemic control and its correlates in patients with diabetes in Venezuela: results from a nationwide survey. Diabetes Res Clin Pract 87: 407-414.
29. Rosen B, Porath A, Pawlson LG, Chassin MR, Benbassat J (2011) Adherence to standards of care by health maintenance organizations in Israel and the USA. Int J Qual Health Care 23: 15-25.
30. Singer SR, Hoshen M, Shadmi E, Leibowitz M, Flaks-Manov N, et al. (2012) EMR-based medication adherence metric markedly enhances identification of nonadherent patients. Am J Manag Care [Epub] 18: e372-7.
31. Nagrebetsky A, Griffin S, Kinmonth AL, Sutton S, Craven A, et al. (2012) Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age. Diabetes Res Clin Pract 96: 119-128.
32. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (2011) Williams Textbook of Endocrinology. 12th Edition. Philadelphia: Elsevier Saunders.
33. Cohen HW, Shmukler C, Ullman R, Rivera CM, Walker EA (2010) Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c). Diabet Med 27: 210-216.
34. Choudry NK, Shrank WH, Levin RL, Lee JL, Jan SA, et al. (2009) Measuring Concurrent Adherence to Multiple Related Medications. Am J Manag Care 15: 457-464.